Cooper Companies Inc (NYSE:COO) – Research analysts at Jefferies Group issued their Q1 2018 earnings per share estimates for shares of Cooper Companies in a report released on Wednesday. Jefferies Group analyst A. Petrone anticipates that the medical device company will post earnings of $2.60 per share for the quarter. Jefferies Group currently has a “Buy” rating and a $250.00 target price on the stock. Jefferies Group also issued estimates for Cooper Companies’ Q2 2018 earnings at $2.74 EPS, Q3 2018 earnings at $2.94 EPS, Q4 2018 earnings at $2.96 EPS, FY2018 earnings at $11.24 EPS, FY2019 earnings at $12.34 EPS and FY2020 earnings at $13.34 EPS.

A number of other brokerages have also recently weighed in on COO. Robert W. Baird reissued a “buy” rating and set a $273.00 price objective (up from $267.00) on shares of Cooper Companies in a report on Tuesday, September 12th. Zacks Investment Research upgraded Cooper Companies from a “hold” rating to a “buy” rating and set a $277.00 price objective on the stock in a report on Tuesday, August 29th. Stifel Nicolaus reiterated a “buy” rating and issued a $265.00 price objective (down from $275.00) on shares of Cooper Companies in a report on Friday. Oppenheimer restated a “hold” rating and issued a $250.00 price objective on shares of Cooper Companies in a research note on Tuesday, September 12th. Finally, Cleveland Research reissued a “buy” rating on shares of Cooper Companies in a research note on Tuesday, August 22nd. Six analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. The stock has an average rating of “Buy” and an average target price of $259.70.

Shares of Cooper Companies (NYSE COO) opened at $226.56 on Friday. The company has a quick ratio of 1.29, a current ratio of 2.51 and a debt-to-equity ratio of 0.38. Cooper Companies has a twelve month low of $168.00 and a twelve month high of $256.39. The company has a market capitalization of $11,689.08, a P/E ratio of 24.57, a P/E/G ratio of 1.99 and a beta of 0.54.

Cooper Companies (NYSE:COO) last announced its quarterly earnings results on Thursday, December 7th. The medical device company reported $2.65 earnings per share for the quarter, beating the Zacks’ consensus estimate of $2.64 by $0.01. The company had revenue of $561.50 million for the quarter, compared to analyst estimates of $558.86 million. Cooper Companies had a net margin of 17.43% and a return on equity of 16.33%. Cooper Companies’s revenue for the quarter was up 8.3% on a year-over-year basis. During the same quarter last year, the business earned $2.28 EPS.

Hedge funds have recently bought and sold shares of the business. ProVise Management Group LLC boosted its holdings in Cooper Companies by 0.6% in the second quarter. ProVise Management Group LLC now owns 1,177 shares of the medical device company’s stock worth $282,000 after acquiring an additional 7 shares in the last quarter. YorkBridge Wealth Partners LLC boosted its position in Cooper Companies by 2.1% during the second quarter. YorkBridge Wealth Partners LLC now owns 531 shares of the medical device company’s stock worth $126,000 after acquiring an additional 11 shares during the last quarter. CIBC Asset Management Inc boosted its position in Cooper Companies by 0.3% during the second quarter. CIBC Asset Management Inc now owns 4,697 shares of the medical device company’s stock worth $1,125,000 after acquiring an additional 16 shares during the last quarter. Wedbush Securities Inc. lifted its holdings in shares of Cooper Companies by 1.0% during the 2nd quarter. Wedbush Securities Inc. now owns 1,783 shares of the medical device company’s stock valued at $427,000 after acquiring an additional 18 shares in the last quarter. Finally, Sentry Investment Management LLC increased its stake in Cooper Companies by 0.7% during the 2nd quarter. Sentry Investment Management LLC now owns 2,801 shares of the medical device company’s stock worth $671,000 after buying an additional 19 shares during the period. 96.79% of the stock is owned by institutional investors.

In other news, Director Gary S. Petersmeyer sold 3,977 shares of the business’s stock in a transaction dated Thursday, September 14th. The shares were sold at an average price of $244.94, for a total value of $974,126.38. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 1.60% of the company’s stock.

COPYRIGHT VIOLATION WARNING: This news story was posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this news story on another publication, it was stolen and reposted in violation of U.S. and international copyright and trademark laws. The legal version of this news story can be accessed at https://www.thecerbatgem.com/2017/12/09/cooper-companies-inc-coo-expected-to-post-q1-2018-earnings-of-2-60-per-share.html.

Cooper Companies Company Profile

The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.

Earnings History and Estimates for Cooper Companies (NYSE:COO)

Receive News & Stock Ratings for Cooper Companies Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies Inc and related stocks with our FREE daily email newsletter.